
I test sleep trackers for a living — you won't find a better Prime Day deal than 15% off the Oura Ring 4
While all of these leading sleep tech brands have built great value, reliable sleep trackers, the Oura Ring is the one I always recommend to friends. Right now the Oura Ring 4 is 15% off at Amazon for Prime Day, cutting the price to less than $300.
We rarely see a discount like this at Oura, which is why this Amazon Prime Day deal is worth snapping up fast. In fact, it's one of the best Prime Day sleep deals we've seen so far.
Oura Ring 4: was from $349 now from $296.65 at AmazonAs the newest smart ring from Oura, the Oura Ring 4 is without doubt one of the best sleep trackers you can buy. It accurately measures everything from time spent in bed through to heart rate variability, sleep stages, overall sleep score and readiness for the day ahead. Amazon is cutting 15% off this Prime Day, reducing the cheapest colorways (silver and black) to $296.65. More expensive models (gold and rose gold) sit at $424.15 (were $499). Just be aware that you'll have to budget for a $5.99/month subscription fee too.
Our review: ★★★★★User score: ★★★★ (3,800+ reviews)
In short, yes, you can trust the Oura Ring's sleep reports. Covering time spent in bed vs time asleep, sleep latency, duration and efficiency, sleep stages and overall sleep quality, they'll deliver plenty of metrics for you to get stuck into.
Don't just take my word for it: a sleep-tracking study by Brigham and Women's Hospital took the Oura Ring Gen 3, Apple Watch Series 8 and Fitbit Sense 2 to the lab to compare them against polysomnography testing (that is, the "gold standard" of sleep assessment). The researchers concluded that the Oura Ring Gen 3 performs the best with up to 10% greater accuracy, especially when it comes to differentiating sleep stages.
This study may be based on the previous generation Oura Ring, but the Ring 4 reportedly comes with upgraded sensors offering up to 120% more accuracy. So, it's safe to say you're in reliable hands with the new ring.
Plus, its sleek design means it sits comfortably on your finger through the night, and it'll last up to seven nights on a single charge.
Oura Ring 3: was $299 now from $199 at OuraThe Oura Ring 3 is an older and cheaper model but, as discussed above, it's scientifically proven to offer great sleep tracking accuracy. There's currently $100 off at Oura while stocks last, cutting the cheaper colors and designs (silver Heritage) to just $199 — an unbeatable price on a sleep and health tracker of this standard. Prices go up to $349 (was $449) for a rose gold Horizon style ring.
Our review: ★★★★½ User score: ★★★★½ (3,900+ reviews)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Entrepreneur
17 minutes ago
- Entrepreneur
What's Really Inside Your Supplements? This Founder Is Uncovering the Truth Behind the $180 Billion Industry
From creatine to NAD+, this company is uncovering the truth behind mislabeled, underdosed and overhyped products. Opinions expressed by Entrepreneur contributors are their own. I recently wrote about creatine and profiled Jeff Byers, co-founder of Momentous, for a reason: integrity matters. When it comes to what we put in our bodies, especially for entrepreneurs aiming to optimize energy, recovery and longevity, founders and consumers deserve transparency and truth. And yet, the supplement industry is booming with very little of either. We're in the middle of a health optimization gold rush. Creatine gummies, NAD+ capsules, sleep pills and brain-boosting stacks are everywhere. Scroll Instagram, walk into Erewhon or search Amazon, and you'll find thousands of options. The global supplement industry is growing fast and is expected to top $240 billion by 2028, yet many of these products do not contain what they claim to. You may be spending $30, $50 or $90 on a supplement and getting barely a trace of the active ingredient, or in some cases, nothing at all. Unlike pharmaceuticals, supplements don't require FDA approval before hitting the market. That creates a loophole where products can launch quickly, and claims, unless dangerously false, go largely unchecked. And it's not just obscure or small brands. Some of the top-selling supplements on Amazon are underdelivering, misleading or worse. That's where Steve Martocci and SuppCo come in. Martocci, best known for founding the music-tech platform Splice, is now on a mission to fix one of the most frustrating problems in wellness: a lack of transparency. SuppCo is a health tech startup that independently tests supplements and publishes public reports that give consumers one thing the industry often avoids: truth. CEO and Co-Founder, Martocci, struggled with his health for most of his life, reaching nearly 300 pounds despite playing three sports and training consistently. Martocci said to me, "Traditional medicine failed me. I remember being told my labs were on the 'low end of normal' and that nothing could be done. It was completely disheartening." After selling GroupMe to Skype, Martocci discovered functional medicine and began working with a doctor on a tailored supplement stack. He lost nearly 100 pounds over the next year and realized that even though supplements had become mainstream, there was no software actually to help people navigate this space. The supplement industry is a $180 billion market, yet it's filled with confusion, noise and a multitude of products that don't deliver what they promise. With SuppCo, Martocci is on a mission to transform how people discover, manage and optimize their supplement routines. Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success. I was introduced to SuppCo's work through their recent Creatine Gummies Report. Creatine, which I personally take and have written about, is one of the most well-researched supplements for both brain and physical performance. But not all products are created equal. SuppCo tested five popular creatine gummy brands sold on Amazon. Only two passed. One contained less than 25% of the labeled amount. SuppCo recently published a report on NAD+ supplements, a trending ingredient in the longevity and cellular energy space, which tested nine products and was even more revealing. 4 passed (Double Wood, Rho Nutrition Liposomal, NatureBell and Thinbi), with Thinbi exceeding its claim at 103%. 5 failed, including Maripolio, which showed 0% of its claimed NAD+. Others tested at less than 3% of the listed amount on the label. NAD+ was the perfect follow-up to the creatine testing series because it represents everything confusing about the supplement space right now. Martocci explained that NAD+ is one of the fastest-rising compounds in longevity and biohacking, endorsed by scientists and influencers, but it's also one of the most confusing for consumers. Martocci said, "You can supplement with NAD+ itself or its precursors like NR and NMN, and most consumers don't understand the bioavailability differences between the three and that one of them is distinctly worse." When we see brands cutting corners on things we can measure, like certifications and testing transparency, they're usually cutting corners on things we can't see too, like what's actually in the bottle. As NAD+ continues to trend for its role in cellular repair and longevity, the gap between marketing and reality becomes even more concerning. Related: Why Top Entrepreneurs Are Swapping Beach Vacations for Longevity Retreats If you're a wellness founder, product integrity is not just a checkbox. It is the heartbeat of your brand. Jeff Byers' company, Momentous, invests in clinical research and testing not because it is required, but because it is what builds lasting trust. Byers told me, "That means showing the science, backing it up with testing, and being radically transparent with our consumers." The next generation of wellness brands will not win on hype. They'll win on data. Consumers are becoming smarter and more demanding, and they want to see the data. SuppCo has already rated over 700 brands and 22,000+ products, and their TrustScore has become remarkably predictive of testing. Now, quality brands are reaching out not just to request a TrustScore, but to get feedback on how to improve their quality practices. When choosing supplements, most people go wrong by treating supplements as if they were all the same. For example, they'll buy the cheapest magnesium without realizing that magnesium oxide has terrible bioavailability compared to magnesium glycinate. Or they'll choose a multivitamin based on how many vitamins are crammed into it, not whether those forms and doses actually work together. Jenna Stangland, co-founder of A4 health and Dietitian for the Minnesota Timberwolves and Minnesota Wild, explains how important it is to ensure that a supplement is tested and validated, as most likely, the dose on the label may not match what is in the bottle and even worse, it could be contaminated. Stangland personally takes NAD+ regularly to support her own energy and help her body adapt to stress and inflammation as she's on airplanes and traveling with teams multiple times per week. Having only tested the creatine and NAD+ categories, SuppCo is just getting started. The company plans to test every major supplement category where there's confusion or questionable quality. This includes protein, magnesium, pre-workouts and nootropics — anywhere consumers are making decisions based on incomplete information, their aim is to bring transparency. Related: Are Your Employees Stressed? You Need to Embrace Transparency. A big milestone they hit recently is the launch of SuppCo Pro, a premium subscription that unlocks deep personalization features. They have received strong user response to their Personal Nutrient Plan, which creates tailored supplement recommendations based on a user's specific goals, as well as their Product Optimizer, which suggests higher-quality, better-value alternatives to what a user is currently taking. This is where the real magic happens, as they can offer truly personalized guidance. I personally appreciate how easy it is to understand their public reports. On the app, you can quickly see whether a product passed or failed, and why. They even launched a browser extension that flags whether the supplement you're browsing has been independently tested. For those of us who care deeply about healthspan, recovery and long-term performance, this kind of transparency is a game-changer.


The Verge
18 minutes ago
- The Verge
Ultimate Ears' Wonderboom 4 speaker is cheaper than ever at 40 percent off
If you're hosting a small get-together or hangout at the park, a small speaker like the UE Wonderboom 4 can provide the soundtrack. It's the kind of gadget that fades into the background yet remains as important as the food and drink. And right now, it's down to just $59.99 ($40 off) at Amazon, Best Buy, and B&H Photo, which is its lowest price to date. The Wonderboom 4's compact design — which is roughly the size of a softball — makes it easy to bring anywhere, whether you're lounging by the pool or cruising on a bike. One of its handiest features is the built-in loop, which allows you to clip on a carabiner and hook it right to your backpack. That way, you can hike with your friends on the trail and everyone can enjoy your outdoor playlist. Despite its smaller size, the battery life is estimated to last up to 14 hours, so you won't have to worry about charging it if you're away from an outlet all day. In addition to all-day battery life, the compact USB-C speaker features an IP67 rating, so it should be able to withstand dust, dirt, and water. And if you're clumsy like me, you'll be happy to know that the speaker is built to endure drops (it even floats). It can also easily connect to Android devices thanks to Google's Fast Pair feature, and you can link two units to create stereo sound, giving you a richer, more immersive listening experience. A few Verge staffers own the Wonderboom 4 and recommend it for its combination of size, sound, and price. We're generally fans of Ultimate Ears' catalog of wireless speakers, which offer decent audio performance, are very durable, and, of course, are easy to transport. The Wonderboom 4 comes in a variety of colors — many of which are on sale — but if you're on the fence for what to get, The Verge's David Pierce recommends the blue. Sign up for Verge Deals to get deals on products we've tested sent to your inbox weekly. Posts from this author will be added to your daily email digest and your homepage feed. See All by Brandon Russell Posts from this topic will be added to your daily email digest and your homepage feed. See All Audio Posts from this topic will be added to your daily email digest and your homepage feed. See All Deals Posts from this topic will be added to your daily email digest and your homepage feed. See All Speakers Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech
Yahoo
an hour ago
- Yahoo
Amazon.com (AMZN) Partners With Sendbird To Enhance AI Capabilities And Market Reach
Sendbird Inc.'s recent collaboration with AWS marks a significant development in the AI agent space, likely aligning positively with market expectations for growth in agentic AI. During the last quarter, saw its stock price move 5%, a change that can be attributed to a combination of factors, including its robust Q2 earnings report and the completion of a substantial share repurchase program. The company's strategic partnerships and expansion initiatives, such as the $10 billion investment in North Carolina for infrastructure, complemented broader market trends, which have been buoyant with the S&P 500 and Nasdaq hitting all-time highs. We've identified 1 weakness with and understanding the impact should be part of your investment process. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. The collaboration between Sendbird Inc. and AWS could enhance Amazon's role in AI-driven solutions, particularly in the AI agent space. This complements the narrative that cloud transition and AI adoption will propel Amazon's growth. The ongoing development in AI, coupled with AWS's leadership, might positively influence future revenue and earnings forecasts, as AWS leverages its infrastructure to meet increasing AI demands. However, competitive and regulatory pressures remain, potentially affecting the ability to maintain margins. Over a three-year period, Amazon's total shareholder return reached 54.56%, underscoring strong performance. This return outpaced the US Multiline Retail industry's one-year performance, where Amazon exceeded the 28.3% industry gain. In comparison to the broader market, Amazon also surpassed the US Market's 19.4% increase over the past year. Considering the current share price of US$221.30 against the consensus price target of US$262.14, there is an 18.46% discount to the target, suggesting room for growth if forecasts align with reality. This potential upside reflects analyst expectations, hinging on whether Amazon can achieve anticipated revenue and earnings milestones. The recent news and strategic developments might aid in closing the gap towards the price target, as market confidence in the company's growth initiatives strengthens. Examine earnings growth report to understand how analysts expect it to perform. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AMZN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data